[PRIMARY SMALL CELL NEUROENDOCRINE CARCINOMA OF THE URETER]

Nihon Hinyokika Gakkai Zasshi. 2018;109(1):30-34. doi: 10.5980/jpnjurol.109.30.
[Article in Japanese]

Abstract

Primary small cell neuroendocrine carcinoma of the upper urinary tract is a rare disease that is associated with a poor prognosis. An 81-year-old man was diagnosed with carcinoma of the stomach and underwent laparoscopic distal gastrectomy. Computed tomography (CT) revealed carcinoma of the left ureter and left hydronephrosis. The patient was diagnosed with carcinoma of the left ureter (cT2N0M0) and left laparoscopic radical nephroureterectomy was performed via a retroperitoneal approach. The pathological diagnosis was left ureter carcinoma (small cell neuroendocrine carcinoma, pT3). He was treated with four courses of the CE regimen (carboplatin area under the curve: 5, intravenously [IV] on day 1 and etoposide [80 mg/m2], IV on days 1-3). There is no evidence of disease at 21 months after radical nephroureterectomy.

Keywords: adjuvant chemotherapy; small cell neuroendocrine carcinoma; ureter carcinoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Neuroendocrine / diagnostic imaging
  • Carcinoma, Neuroendocrine / therapy*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Etoposide / administration & dosage
  • Gastrectomy
  • Humans
  • Laparoscopy* / methods
  • Male
  • Neoplasms, Multiple Primary / therapy*
  • Nephroureterectomy* / methods
  • Stomach Neoplasms / surgery
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ureteral Neoplasms / diagnostic imaging
  • Ureteral Neoplasms / therapy*
  • Urologic Surgical Procedures, Male / methods

Substances

  • Etoposide
  • Carboplatin

Supplementary concepts

  • JET protocol